Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent A Fusaro

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of the American Medical Informatics Association : JAMIA|June 16, 2016
Creating a scalable clinical pharmacogenomics service with automated interpretation and medical record result integration - experience from a pediatric tertiary care facilityShannon F Manzi, Vincent A Fusaro, Laura Chadwick, et al.
Annals of the New York Academy of Sciences|January 25, 2003
Proteomic technologies to study diseases of the lymphatic vascular systemLee V Leak, Emanuel F Petricoin, Michael Jones, et al.
Nucleic Acids Research|October 13, 2007
Many Microbe Microarrays Database: uniformly normalized Affymetrix compendia with structured experimental metadataJeremiah J Faith, Michael E Driscoll, Vincent A Fusaro, et al.
Proteomics|March 5, 2004
Proteomic analysis of lymphLee V Leak, Lance A Liotta, Henry Krutzsch, et al.
Plos One|November 14, 2013
Early detection of poor adherers to statins: applying individualized surveillance to pay for performanceAndrew J Zimolzak, Claire M Spettell, Joaquim Fernandes, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Kauro, a graph-based chatbot for high-fidelity information transmission conversationsCharles Hadley King, Rebekah Barrick, Miguel Almalvez, et al.
The Journal of Urology|September 17, 2004
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/mlDavid K Ornstein, Walter Rayford, Vincent A Fusaro, et al.
Disease Markers|July 20, 2004
Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patientsDonald J Johann, Michael D McGuigan, Stanimire Tomov, et al.
Lancet (London, England)|February 28, 2002
Use of proteomic patterns in serum to identify ovarian cancerEmanuel F Petricoin, Ali M Ardekani, Ben A Hitt, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
"Development and Implementation of Novel Chatbot-based Genomic Research Consent"Erica D Smith, Sarah K Savage, E Hallie Andrew, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of the American Medical Informatics Association : JAMIA|June 16, 2016
Creating a scalable clinical pharmacogenomics service with automated interpretation and medical record result integration - experience from a pediatric tertiary care facilityShannon F Manzi, Vincent A Fusaro, Laura Chadwick, et al.
Annals of the New York Academy of Sciences|January 25, 2003
Proteomic technologies to study diseases of the lymphatic vascular systemLee V Leak, Emanuel F Petricoin, Michael Jones, et al.
Nucleic Acids Research|October 13, 2007
Many Microbe Microarrays Database: uniformly normalized Affymetrix compendia with structured experimental metadataJeremiah J Faith, Michael E Driscoll, Vincent A Fusaro, et al.
Proteomics|March 5, 2004
Proteomic analysis of lymphLee V Leak, Lance A Liotta, Henry Krutzsch, et al.
Plos One|November 14, 2013
Early detection of poor adherers to statins: applying individualized surveillance to pay for performanceAndrew J Zimolzak, Claire M Spettell, Joaquim Fernandes, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Kauro, a graph-based chatbot for high-fidelity information transmission conversationsCharles Hadley King, Rebekah Barrick, Miguel Almalvez, et al.
The Journal of Urology|September 17, 2004
Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/mlDavid K Ornstein, Walter Rayford, Vincent A Fusaro, et al.
Disease Markers|July 20, 2004
Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patientsDonald J Johann, Michael D McGuigan, Stanimire Tomov, et al.
Lancet (London, England)|February 28, 2002
Use of proteomic patterns in serum to identify ovarian cancerEmanuel F Petricoin, Ali M Ardekani, Ben A Hitt, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
"Development and Implementation of Novel Chatbot-based Genomic Research Consent"Erica D Smith, Sarah K Savage, E Hallie Andrew, et al.
Pageof 4